SPAC11D3.08c Antibody

What is SPAC11D3.08c and why is it a target for antibody development?

SPAC11D3.08c is a protein encoded by the SPAC11D3.08c gene in Schizosaccharomyces pombe (fission yeast). The antibody against this protein serves as an essential research tool for studying protein expression, localization, and function in S. pombe cellular processes. The antibody was developed to enable detection of this specific protein in various experimental contexts such as Western blotting and ELISA techniques. This polyclonal antibody was raised in rabbits using recombinant Schizosaccharomyces pombe (strain 972/ATCC 24843) SPAC11D3.08c protein as the immunogen, making it highly specific for this particular fission yeast protein . Understanding its target protein provides researchers with insights into cellular mechanisms in this model organism.

What are the validated applications for SPAC11D3.08c Antibody?

The SPAC11D3.08c Antibody has been validated for use in specific laboratory techniques including:

• Enzyme-Linked Immunosorbent Assay (ELISA)

• Western Blotting (WB)

These applications have been specifically tested to ensure identification of the target antigen . The antibody's affinity purification process enhances its specificity and reduces background noise in these applications. For optimal results in Western blotting, researchers should use standard protocols with appropriate blocking agents and secondary antibodies compatible with rabbit IgG. When planning experiments, consider that this antibody is supplied in liquid form with a storage buffer containing 0.03% Proclin 300, 50% Glycerol, and 0.01M PBS at pH 7.4 .

What are the optimal storage conditions for maintaining SPAC11D3.08c Antibody activity?

To maintain optimal reactivity and specificity of the SPAC11D3.08c Antibody, proper storage conditions are critical. The manufacturer recommends storing the antibody at -20°C or -80°C upon receipt . Repeated freeze-thaw cycles should be avoided as they can degrade the antibody and compromise its performance. If frequent use is anticipated, aliquoting the antibody into smaller volumes before freezing is recommended to minimize freeze-thaw cycles. The antibody is supplied in a buffer containing 50% glycerol, which helps prevent freezing damage and maintains stability during storage . For short-term storage (1-2 weeks), keeping the antibody at 4°C is acceptable, but long-term storage should always be at -20°C or preferably -80°C for maximum shelf life and retained activity.

How should I optimize Western blot protocols specifically for SPAC11D3.08c detection?

Optimizing Western blot protocols for SPAC11D3.08c detection requires several specific considerations. First, protein extraction from S. pombe cells should be performed using methods that preserve protein integrity while efficiently lysing the rigid yeast cell wall. A recommended approach is using glass bead disruption in the presence of protease inhibitors. For gel electrophoresis, a 10-12% SDS-PAGE gel typically provides optimal resolution for this protein. Transfer conditions should be adjusted based on protein size, with semi-dry transfer at 15V for 30 minutes often yielding good results for yeast proteins.

For blocking, 5% non-fat dry milk in TBST (Tris-buffered saline with 0.1% Tween-20) for 1-2 hours at room temperature is recommended to minimize background. The primary antibody (SPAC11D3.08c Antibody) should be diluted at 1:1000 to 1:2000 in blocking solution and incubated overnight at 4°C for optimal binding . After washing with TBST (3 × 10 minutes), apply HRP-conjugated anti-rabbit secondary antibody at 1:5000 dilution for 1 hour at room temperature. Following additional washing steps, detection can be performed using enhanced chemiluminescence reagents with exposure times optimized empirically for your specific sample.

What controls should be included when using SPAC11D3.08c Antibody in research applications?

When designing experiments with SPAC11D3.08c Antibody, incorporating appropriate controls is essential for result validation:

Positive Controls:

• Lysates from wild-type S. pombe (strain 972/ATCC 24843) expressing native SPAC11D3.08c

• Recombinant SPAC11D3.08c protein (same as used for immunization)

Negative Controls:

• SPAC11D3.08c knockout or deletion strain lysates

• Heterologous cell lysates (e.g., S. cerevisiae or mammalian cells)

Technical Controls:

• Primary antibody omission control

• Isotype control (non-specific rabbit IgG at the same concentration)

• Pre-immune serum control

Loading Controls:

• Detection of constitutively expressed S. pombe proteins (e.g., actin or tubulin)

Including these controls helps validate specificity, eliminate false positives, and ensure reliable interpretation of experimental results. When troubleshooting unexpected results, systematically evaluating these controls can identify the source of experimental variability or technical issues .

What cross-reactivity considerations should researchers address when working with SPAC11D3.08c Antibody?

Although the SPAC11D3.08c Antibody is raised against a specific S. pombe protein, researchers should be aware of potential cross-reactivity issues. This polyclonal antibody might recognize epitopes shared with homologous proteins in closely related species. The antibody is specifically reactive with Schizosaccharomyces pombe (strain 972/ATCC 24843) , but sequence homology analysis should be performed to identify potential cross-reactive proteins in your experimental system.

When working with mixed samples or multiple yeast species, preliminary validation through Western blotting comparing different species' lysates is recommended. Pre-absorption techniques can be employed if cross-reactivity is observed; this involves incubating the antibody with recombinant non-target proteins that show homology to SPAC11D3.08c. Epitope mapping could also help identify which regions of SPAC11D3.08c are recognized by the antibody, providing insight into potential cross-reactivity with related proteins. For definitive confirmation of specificity, parallel experiments using CRISPR/Cas9-generated SPAC11D3.08c knockout strains can serve as negative controls.

How can SPAC11D3.08c Antibody be utilized in protein-protein interaction studies?

SPAC11D3.08c Antibody can be effectively employed in various protein-protein interaction studies to elucidate the functional relationships of this protein within cellular pathways. For co-immunoprecipitation (Co-IP) experiments, researchers should optimize lysis conditions to preserve native protein complexes while efficiently extracting proteins from S. pombe cells. Typically, gentle lysis buffers containing 150mM NaCl, 50mM Tris-HCl (pH 7.5), 1% NP-40, and protease inhibitors work well for yeast samples.

The antibody can be coupled to protein A/G beads using standard protocols or commercial kits designed for rabbit IgG. For each Co-IP reaction, 2-5μg of SPAC11D3.08c Antibody per 500μg of total protein lysate is recommended. After overnight incubation at 4°C with gentle rotation, wash the immunoprecipitated complexes thoroughly (at least 4-5 washes) to minimize non-specific binding. Proteins can then be eluted and analyzed by Western blotting to identify interacting partners.

For more advanced approaches, the antibody can be used in proximity-dependent biotin identification (BioID) or crosslinking immunoprecipitation approaches. When designing these experiments, researchers should validate the specificity of interactions by including appropriate controls and confirming results with reciprocal Co-IP experiments where possible .

What strategies can improve immunofluorescence results when using SPAC11D3.08c Antibody in S. pombe cells?

Optimizing immunofluorescence protocols for S. pombe cells using SPAC11D3.08c Antibody requires addressing the unique challenges of fission yeast cell wall and fixation issues. Begin with fresh cultures in logarithmic growth phase for optimal protein expression and cellular morphology. For cell wall digestion, use 5mg/ml zymolyase in appropriate buffer for 30-60 minutes at 37°C, monitoring digestion progress microscopically to prevent over-digestion.

Fixation can be performed with 4% paraformaldehyde for 30 minutes at room temperature, followed by permeabilization with 0.1% Triton X-100 for 10 minutes. Blocking should be thorough (1-2 hours) using 5% BSA or normal goat serum in PBS to minimize background signal. For primary antibody incubation, use SPAC11D3.08c Antibody at a 1:100 to 1:500 dilution in blocking buffer overnight at 4°C.

After washing (3-5 times with PBS containing 0.1% Tween-20), apply fluorophore-conjugated anti-rabbit secondary antibodies at 1:500 dilution for 1-2 hours at room temperature. Include DAPI (1μg/ml) during the final wash to visualize nuclei. Mount slides using anti-fade mounting medium to prevent photobleaching during microscopy. For improved results, consider using super-resolution microscopy techniques to resolve subcellular localization with greater precision.

How can researchers validate SPAC11D3.08c Antibody specificity in their experimental system?

Validating antibody specificity is critical for ensuring reliable experimental results. For SPAC11D3.08c Antibody, a multi-faceted validation approach is recommended:

• Genetic validation: Compare wild-type S. pombe cells with SPAC11D3.08c knockout or knockdown strains. The antibody should detect the protein in wild-type samples but show significantly reduced or absent signal in knockout/knockdown samples.

• Overexpression validation: Engineer strains that overexpress SPAC11D3.08c, potentially with an epitope tag. The antibody should detect increased signal in overexpression samples compared to wild-type controls.

• Mass spectrometry verification: Perform immunoprecipitation with the SPAC11D3.08c Antibody followed by mass spectrometry analysis to confirm that the precipitated protein is indeed SPAC11D3.08c.

• Epitope competition assay: Pre-incubate the antibody with excess purified antigen (recombinant SPAC11D3.08c protein) before using it in Western blotting or immunofluorescence. This should result in significantly reduced or abolished signal.

• Size verification: In Western blots, verify that the detected band corresponds to the expected molecular weight of SPAC11D3.08c.

This comprehensive validation approach ensures that experimental observations truly reflect SPAC11D3.08c behavior rather than artifacts from non-specific antibody binding .

What are common causes of false negative results when using SPAC11D3.08c Antibody?

False negative results when using SPAC11D3.08c Antibody can stem from various technical and biological factors. One primary cause is inefficient protein extraction from S. pombe cells due to the rigid yeast cell wall. To address this, optimize lysis conditions using methods like glass bead disruption or enzymatic cell wall digestion with zymolyase. Protein degradation during sample preparation can also lead to false negatives, so always include fresh protease inhibitors in lysis buffers and keep samples cold.

Another common issue is suboptimal antibody concentration. If signal is weak or absent, try using higher antibody concentrations (1:500 instead of 1:2000) or extending incubation times. Improper storage of the antibody can reduce its activity; avoid repeated freeze-thaw cycles and store at -20°C or -80°C as recommended .

For Western blotting specifically, inefficient protein transfer to membranes may cause false negatives. Verify transfer efficiency using reversible protein stains like Ponceau S. If the target protein is present at low abundance, consider enrichment techniques like immunoprecipitation before analysis. Finally, some epitopes may be masked by protein folding or post-translational modifications, so try different denaturation conditions or sample preparation methods to expose these epitopes.

How can researchers differentiate between specific and non-specific bands in Western blots using SPAC11D3.08c Antibody?

Differentiating between specific and non-specific bands requires systematic analysis and appropriate controls. The expected molecular weight of SPAC11D3.08c should be determined from its amino acid sequence (with consideration for potential post-translational modifications) and compared with observed bands. Specific bands should:

• Appear at the expected molecular weight

• Show consistent intensity relative to sample loading

• Disappear or diminish in knockout/knockdown samples

• Increase in intensity in overexpression samples

• Be competed away in epitope competition assays

To reduce non-specific binding, optimize blocking conditions (try 5% BSA instead of milk if background is high) and increase the number and duration of wash steps. Titrate the antibody concentration to find the optimal dilution that maximizes specific signal while minimizing background. For persistent non-specific bands, try more stringent washing conditions or consider alternative detection methods like fluorescent secondary antibodies that may offer better signal-to-noise ratios than chemiluminescence.

If multiple bands persist, peptide competition assays can help identify which band represents SPAC11D3.08c. Additionally, immunoprecipitation followed by mass spectrometry can definitively identify the protein corresponding to each observed band .

What consideration should be given to post-translational modifications when interpreting SPAC11D3.08c Antibody results?

Post-translational modifications (PTMs) can significantly impact SPAC11D3.08c detection and result interpretation. PTMs may alter protein migration on SDS-PAGE gels, resulting in bands at unexpected molecular weights. Common modifications like phosphorylation typically cause slight upward shifts, while proteolytic processing may generate smaller fragments. When multiple bands are observed, consider that they might represent differently modified forms of SPAC11D3.08c rather than non-specific binding.

To investigate PTMs, researchers can employ:

• Phosphatase treatment: Treating samples with lambda phosphatase before SDS-PAGE can reveal whether bands represent phosphorylated forms of SPAC11D3.08c.

• PTM-specific enrichment: Techniques like phosphopeptide enrichment coupled with mass spectrometry can identify specific modified residues.

• Site-directed mutagenesis: Mutating putative modification sites and comparing the banding pattern can confirm the presence and location of specific PTMs.

• 2D gel electrophoresis: This approach can separate proteins based on both molecular weight and isoelectric point, helping to distinguish between differently modified forms.

When designing experiments, consider cell cycle phase and growth conditions, as these may affect the PTM status of SPAC11D3.08c. For publication-quality data, validation of PTM status using multiple complementary techniques is recommended .

How does SPAC11D3.08c Antibody compare with other antibodies targeting S. pombe proteins?

The SPAC11D3.08c Antibody shares methodological similarities with other S. pombe antibodies while maintaining target specificity. When comparing with related antibodies such as SPAC11D3.01c (Q10080), SPAC11D3.14c (Q10093), and SPAC11D3.18c (Q10097) , researchers should note several important distinctions and commonalities:

All these antibodies are made-to-order with similar lead times (14-16 weeks) and are suitable for research use only . When selecting between these related antibodies, consider their target protein's function, cellular localization, and expression level in your experimental system. Cross-reactivity testing may be necessary when studying multiple SPAC11D3 family proteins simultaneously.

What relevant research pathways involve SPAC11D3.08c in S. pombe studies?

While specific pathways involving SPAC11D3.08c are not extensively detailed in the provided search results, fission yeast studies frequently investigate conserved cellular mechanisms. Based on research patterns in S. pombe, potential pathways that might involve SPAC11D3.08c include:

• Cell cycle regulation: Many S. pombe proteins participate in cell division control mechanisms, which are highly conserved across eukaryotes.

• Stress response pathways: Fission yeast proteins often function in cellular responses to environmental stressors such as nutrient limitation, oxidative stress, or temperature changes.

• TSC signaling pathway: Related research in S. pombe has examined the TSC (Tuberous Sclerosis Complex) pathway, which regulates cell growth and protein synthesis in response to nutrient availability and cellular energy status .

• Meiosis and sexual differentiation: S. pombe is a valuable model for studying the transition from mitotic to meiotic cell division, with many proteins showing differential regulation during this process.

Researchers studying SPAC11D3.08c should consider performing co-immunoprecipitation followed by mass spectrometry to identify interacting proteins, which could help place this protein within specific cellular pathways. Comparative genomics approaches analyzing conserved domains across species might also provide insights into functional pathways .

How should researchers interpret SPAC11D3.08c Antibody results in the context of fission yeast mutant studies?

When interpreting SPAC11D3.08c Antibody results in mutant studies, researchers should consider several contextual factors. First, establish baseline expression levels and localization patterns in wild-type S. pombe under standard conditions. This provides a reference point for comparing protein behavior in various mutant backgrounds. When examining SPAC11D3.08c in deletion or mutation strains of other genes, consider whether observed changes in expression, localization, or modification state are direct or indirect effects.

For epistasis analysis, examine SPAC11D3.08c expression and localization in single and double mutant combinations to determine genetic relationships between SPAC11D3.08c and other genes of interest. Changes in SPAC11D3.08c expression or localization in response to mutations in upstream regulators can help place it within signaling cascades.

Consider also how cell cycle phase affects interpretation - some phenotypes may only be apparent during specific cell cycle stages. For temperature-sensitive mutants, perform experiments at both permissive and restrictive temperatures to distinguish between immediate and adaptive responses. When publishing results, include comprehensive strain information, growth conditions, and antibody validation data to ensure reproducibility .

What emerging techniques can enhance SPAC11D3.08c protein studies beyond conventional antibody applications?

Emerging technologies are expanding the research toolkit beyond traditional antibody applications. CRISPR/Cas9 genome editing now allows precise tagging of endogenous SPAC11D3.08c with fluorescent proteins or affinity tags, enabling live-cell imaging and purification without antibody limitations. Proximity-dependent labeling methods like BioID or APEX can identify transient interaction partners by fusing biotin ligase to SPAC11D3.08c, providing spatial proteomics data beyond conventional co-immunoprecipitation.

Advanced microscopy techniques including super-resolution microscopy (STORM, PALM) and lattice light-sheet microscopy offer unprecedented spatial resolution and reduced phototoxicity for visualizing SPAC11D3.08c dynamics in living cells. For protein structure studies, cryo-electron microscopy now achieves near-atomic resolution without crystallization requirements.

Single-cell proteomics approaches can reveal cell-to-cell variability in SPAC11D3.08c levels, while mass spectrometry imaging techniques allow spatial mapping of protein distribution across colonies or tissues. These techniques complement rather than replace antibody-based detection, offering researchers multidimensional data for comprehensive understanding of SPAC11D3.08c function in cellular contexts.

How can researchers effectively combine genetic and biochemical approaches when studying SPAC11D3.08c?

An integrated approach combining genetic manipulation with biochemical characterization provides the most comprehensive understanding of SPAC11D3.08c function. Begin by creating a suite of genetic tools: knockout strains to determine essentiality, conditional mutants for studying essential functions, and strains with endogenously tagged SPAC11D3.08c (with GFP, HA, or TAP tags). These genetic tools provide the foundation for subsequent biochemical analyses.

For biochemical characterization, use SPAC11D3.08c Antibody in combination with tagged constructs to validate expression, localization, and interaction partners. Combine traditional approaches like Western blotting with advanced techniques such as chromatin immunoprecipitation (if SPAC11D3.08c has potential DNA-binding activity) or ribosome profiling (if it may be involved in translation).

A particularly powerful strategy is to perform quantitative proteomic analysis comparing wild-type and SPAC11D3.08c mutant strains under various growth conditions or stresses. This reveals both direct interaction partners and downstream effectors. When phenotypes are identified, connect them to biochemical mechanisms through targeted assays addressing specific cellular processes. For example, if growth defects are observed, measure relevant metabolic parameters; if cell morphology is affected, examine cytoskeletal components.